Comparative Efficacy and Harms of Duloxetine, Milnacipran, and Pregabalin in Fibromyalgia Syndrome

This publication has 43 references indexed in Scilit:

• Inadequate reporting of trials compromises the applicability of systematic reviews
  International Journal of Technology Assessment in Health Care, 2009
• Safety and tolerability of duloxetine in the treatment of patients with fibromyalgia: pooled analysis of data from five clinical trials
  Clinical Rheumatology, 2009
• Gabapentin Versus Tricyclic Antidepressants for Diabetic Neuropathy and Post-Herpetic Neuralgia: Discrepancies Between Direct and Indirect Meta-Analyses of Randomized Controlled Trials
  Journal of General Internal Medicine, 2008
• A six-month double-blind, placebo-controlled, randomized clinical trial of duloxetine for the treatment of fibromyalgia
  International Journal of General Medicine, 2008
• Milnacipran for the treatment of fibromyalgia in adults: A 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial
  Clinical Therapeutics, 2008
• Identifying the clinical domains of fibromyalgia: Contributions from clinician and patient delphi exercises
  Arthritis Care & Research, 2008
• Was sind die Kernsymptome des Fibromyalgiesyndroms?
  Der Schmerz, 2007
• An internet survey of 2,596 people with fibromyalgia
  BMC Musculoskeletal Disorders, 2007
• Why Most Published Research Findings Are False
  PLOS Medicine, 2005
• The american college of rheumatology 1990 criteria for the classification of fibromyalgia
  Arthritis & Rheumatism, 1990